CLEARMIND MEDICINE INC (CMND) Stock Income Statement
NASDAQ:CMND - Nasdaq - CA1850534027 - Common Stock - Currency: USD
| TTM (2025-1-31) | 2024 (2024-10-31) | 2023 (2023-10-31) | 2022 (2022-10-31) | 2021 (2021-10-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | N/A | 0.00 | 0.00 | |||
| Operating Expenses | 5.86M | 5.74M | 6.30M | 6.25M | 2.71M | |||
| Research and Development | 1.62M | 1.38M | 1.54M | 3.08M | 475.90K | |||
| Selling, General, and Administrative Expenses | 4.24M | 4.32M | 4.76M | 3.16M | 2.23M | |||
| Operating Income | -5.86M | -5.74M | -6.30M | -6.25M | -2.71M | |||
| Interest Income/Expense | 1.16M | 904.40K | -2.30M | -613.60K | -24.70K | |||
| Other Income/Expense | N/A | -36.20K | N/A | N/A | N/A | |||
| Non Recurring Items | N/A | N/A | 0.00 | 0.00 | -7.40K | |||
| Income Before Taxes | -4.74M | -4.88M | -8.60M | -6.87M | -2.74M | |||
| Income Tax | 215.80K | 378.00K | 17.40K | 29.90K | N/A | |||
| Net Income | -4.96M | -5.25M | -8.62M | -6.89M | -2.74M | |||
| EBITDA | -5.80M | -5.69M | -6.25M | -6.17M | -2.70M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.32 | -1.70 | -42.58 | -159.11 | -88.59 | |||
| Statistics | ||||||||
All data in USD